Your browser doesn't support javascript.
loading
[Continuous glucose monitoring data: how can they be collected and used in practice?] / Les données de la mesure continue du glucose : comment les récupérer et pour quel usage dans la pratique ?
Prévost, Gaëtan.
Afiliación
  • Prévost G; Normandie Université, UNIVROUEN, Inserm U1239, CHU Rouen, service d'endocrinologie, diabète et maladies métaboliques, F-76000 Rouen, France.
Rev Prat ; 74(3): S13-S17, 2024 Mar.
Article en Fr | MEDLINE | ID: mdl-38551885
ABSTRACT
CONTINUOUS GLUCOSE MONITORING DATA HOW CAN THEY BE COLLECTED AND USED IN PRACTICE? Continuous glucose monitoring (CGM) is becoming an essential part of diabetes management. The AGP report is obtained over a 14-day period, with at least 70% of captured data. The time spent in the 70-180 mg/dl targel range, withe a target of over 70% or 50% in frail patients, is a new parameter that is essential for assessing glycemic control via CGM. Complemented by estimated HBA1c, now called GMI (Glucose Management Indicator), the time spent in hypoglycemia (target inférieur 5% or even inférieur 1% for frail patients) and the coefficient of variation (target inférieur 36%), the CGM offers a very comprehensive analysis of blood glucose levels, with individualized treatment adjustments based on ambulatory blood glucose profiles.
Asunto(s)
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipoglucemia Límite: Humans Idioma: Fr Revista: Rev Prat Año: 2024 Tipo del documento: Article País de afiliación: Francia
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipoglucemia Límite: Humans Idioma: Fr Revista: Rev Prat Año: 2024 Tipo del documento: Article País de afiliación: Francia